Christof Fellmann

Christof Fellmann is the Head of CRISPR-X and Executive Director at CRISPR Therapeutics since August 2022, and an Affiliate Investigator and Research Investigator at the Gladstone Institute of Data Science and Biotechnology since July 2018, where the Fellmann lab focuses on cancer progression, therapy, and CRISPR-Cas methodologies. Additionally, Christof serves as an Assistant Adjunct Professor in the Department of Cellular & Molecular Pharmacology at the University of California, San Francisco, and holds a prior position as a Postdoctoral Scholar at UC Berkeley under Nobel Laureate Jennifer A. Doudna. Previously, Christof co-founded and acted as Chief Scientific Officer at Mirimus, Inc., specializing in RNA interference technologies. Christof's academic background includes a Ph.D. from Cold Spring Harbor Laboratory and an engineering degree in Biotechnology from ESBS, along with foundational studies in Molecular Biology at the University of Basel.